Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-026375

President and CEO sold 19,473 shares at an average $8.93 ($173,991)

  • President and CEO acquired 43,028 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KANE MATTHEW R. President and CEO 2021-04-08 Option exercise +21,514 $0.04 $861 1,950,982 D: show line 1 in the form
KANE MATTHEW R. President and CEO 2021-04-08 Sale −9,736 $9.00 $87,624 1,941,246 D: show line 2 in the form
KANE MATTHEW R. President and CEO 2021-04-09 Option exercise +21,514 $0.04 $861 1,962,760 D: show line 3 in the form
KANE MATTHEW R. President and CEO 2021-04-09 Sale −9,737 $8.87 $86,367 1,953,023 D: show line 4 in the form
Open-market sales · 19,473 sh · avg $8.93 · $173,991

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KANE MATTHEW R. President and CEO 2021-04-08 Option exercise · Employee Stock Option (Right to Buy) −21,514 107,570 D: show line 5 in the form
KANE MATTHEW R. President and CEO 2021-04-09 Option exercise · Employee Stock Option (Right to Buy) −21,514 86,056 D: show line 6 in the form
Loading xslF345X03/doc4.xml…